RESEARCH Open Access Mechanism Of Metabolic Stroke And .

3y ago
30 Views
2 Downloads
9.86 MB
15 Pages
Last View : 17d ago
Last Download : 3m ago
Upload by : Nixon Dill
Transcription

Zinnanti et al. Acta Neuropathologica Communications 2014, SEARCHOpen AccessMechanism of metabolic stroke and spontaneouscerebral hemorrhage in glutaric aciduria type IWilliam J Zinnanti1*, Jelena Lazovic2, Cathy Housman3, David A Antonetti4, David M Koeller5, James R Connor6and Lawrence Steinman1AbstractBackground: Metabolic stroke is the rapid onset of lasting central neurological deficit associated withdecompensation of an underlying metabolic disorder. Glutaric aciduria type I (GA1) is an inherited disorder of lysineand tryptophan metabolism presenting with metabolic stroke in infancy. The clinical presentation includes bilateralstriatal necrosis and spontaneous subdural and retinal hemorrhages, which has been frequently misdiagnosed asnon-accidental head trauma. The mechanisms underlying metabolic stroke and spontaneous hemorrhage arepoorly understood.Results: Using a mouse model of GA1, we show that metabolic stroke progresses in the opposite sequence ofischemic stroke, with initial neuronal swelling and vacuole formation leading to cerebral capillary occlusion. Focalregions of cortical followed by striatal capillaries are occluded with shunting to larger non-exchange vessels leadingto early filling and dilation of deep cerebral veins. Blood–brain barrier breakdown was associated with displacementof tight-junction protein Occludin.Conclusion: Together the current findings illuminate the pathophysiology of metabolic stroke and vascularcompromise in GA1, which may translate to other neurometabolic disorders presenting with stroke.Keywords: Metabolic stroke, Glutaric aciduria, Blood–brain barrier, Cerebral hemorrhageBackgroundIschemic and hemorrhagic strokes have been extensivelycharacterized and studied [1,2]. A third type of stroke,known as metabolic stroke, begins with metabolic dysfunction and leads to a rapid onset of lasting focal brainlesions in the absence of large vessel rupture or occlusion [3-5]. The mechanism by which global metabolicdysfunction leads to focal brain injury in metabolicstroke is not well understood. Pure metabolic stroke isroutinely reported in glutaric, isovaleric, methylmalonicand propionic acidurias [5]. Additionally, the organicacidurias have been associated with spontaneous intracranial hemorrhage, suggesting a vascular componentmay contribute to brain injury in these disorders [6,7].The subdural and retinal hemorrhages frequently foundin glutaric aciduria type I (GA1) may be mistaken fornon-accidental head trauma, with severe legal and* Correspondence: wzinnanti@gmail.com1Department of Neurology and Neurological Science, Stanford University,Stanford, CA 94305, USAFull list of author information is available at the end of the articleemotional consequences for families [7,8]. The etiologicrole of vascular pathology in metabolic stroke has notbeen previously elucidated.GA1 provides a prototypical model for metabolic strokeas more than 90% of children with this disease will experience bilateral basal ganglia injury if not identified andtreated pre-symptomatically [9,10]. The disorder is causedby a deficiency of glutaryl-coenzyme-A dehydrogenase(EC 1.3.99.7; GCDH), inherited as an autosomal recessivecondition [11]. GCDH is required for complete oxidationof lysine, hydroxylysine and tryptophan. Affected individuals accumulate glutaric and 3-hydroxy-glutaric acids inthe brain, which are believed to play a primary role in thepathophysiology of the disease. As one of the more common inherited metabolic disorders, GA1 affects 1:30,000to 1:100,000 children worldwide [9,12], with an increasedfrequency in genetically isolated populations such as OldOrder Amish, Canadian Ojibway Cree natives, Irish Travelers, and native South Africans [10,13-15]. Children withGA1 typically develop normally through early infancy, butthen may experience an encephalopathic crisis associated 2014 Zinnanti et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the CreativeCommons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedicationwaiver ) applies to the data made available in this article, unless otherwisestated.

Zinnanti et al. Acta Neuropathologica Communications 2014, th non-specific illness between 6 and 36-months of age[11]. Prevention is critical as the encephalopathic crisisusually results in irreversible bilateral striatal injury withsubstantial morbidity including crippling dystonia, choreathetosis and shortened life span [11].An animal model of GA1 encephalopathy was developedby providing GCDH-deficient (Gcdh / ) mice with a highlysine or protein diet [16]. Recent work with this modelshowed age-dependent susceptibility to acute brain injurysimilar to human GA1 that was associated with differencesin the amount of brain lysine accumulation and subsequent conversion to glutaric acid in 4-week versus 8-weekold Gcdh / mice [17]. The young Gcdh / mice sufferseizures, paralysis, hemorrhages, and death within 3-6days of lysine or protein diet exposure, with the acuteaccumulation of brain glutaric acid at levels found inhuman autopsy cases. Encephalopathy in Gcdh / micewas associated with energy deprivation, detected as depletion of α - ketoglutarate (α KG), ATP and phosphocreatine [17]. Adult ( 8-week old) Gcdh / micesurvive after consuming the same high lysine diet, butall develop bilateral striatal necrosis after 6-weeks [16].Since the young Gcdh / mice develop hemorrhagesand striatal injury similar to human GA1, this modelprovides the opportunity to investigate the specific vascular changes associated with an acute encephalopathiccrisis. In the current study we first describe the neuropathology to guide our subsequent investigations, andthen capture the evolution of the metabolic stroke including associated perfusion abnormalities. Additionally,we investigated the effect of metabolic compromise onthe integrity of the blood–brain barrier (BBB), and potential changes in levels of vascular endothelial growthfactor (VEGF) and hypoxia inducible factor 1-alpha(HIF-1 α). Our current findings detail the mechanism ofbrain injury in metabolic stroke and provide detailed evidence linking metabolic dysfunction to specific BBB abnormalities in Gcdh / mice. These data are likelytranslational to patients with GA1 as well as other neurometabolic disorders presenting with stroke.MethodsMaterialsAll chemicals were purchased from Sigma (St Louis,MO, USA) unless otherwise specified.AnimalsGcdh / mice and age-matched wild type (WT) or heterozygous (Gcdh / ) controls, both of mixed C57Bl/6 JX 129SvEv background [18], were generated from homozygotes maintained at Penn State College of Medicine(Department of Comparative Medicine) All animal experiments were reviewed and approved in accordance withIACUC research guidelines set forth by Pennsylvania StatePage 2 of 15University and the Society for Neuroscience Policy on theuse of animals in neuroscience research as previously described [17].Special dietsDiets were purchased from Harland Teklad (Indianapolis,IN, USA). The standard diet was the Harland Teklad 2018diet, which is 18% protein and provides 1% lysine byweight. The protein diet (TD.03637) (70% casein) contains62% protein, which is 4.7% lysine by weight. The lysinediet (TD.04412) was prepared by adding free lysine to astandard diet to achieve 4.7% total lysine. This level oflysine is not toxic in normal animals [19,20]. All specialdiet treated animals were evaluated daily for symptoms aspreviously described [16]. In order to reduce the numberof animals used for these experiments, the protein dietwas used for all histology experiments [16]. The lysinediet, which causes a slower onset of encephalopathy, wasused for MRI experiments to avoid animals being too illto be scanned and for long-term studies such as the BBBprotein analysis.NeuropathologySix 4-week old Gcdh / , 3 WT and 3 Gcdh / micewere sacrificed before starting the diet (0 hour control).To follow the earliest pathologic events, 36 Gcdh / , 3WT and 3 Gcdh / mice were placed on a high proteindiet at 4-weeks of age. Six Gcdh / mice were sacrificedevery 12-hours after starting the diet and 3 WT and 3Gcdh / mice were sacrificed at 72-hours with the last6 Gcdh / mice. A second group of 36 Gcdh / , 6 WTand 6 Gcdh / mice were placed on the lysine diet at4-weeks of age and processed similarly. All the abovemice were perfusion fixed and processed for histologyand electron microscopy. Four additional Gcdh / micewere immersion fixed to show in situ red blood cellsand engorged vessels.All mice were anesthetized with 100 mg/kg pentobarbital(i.p.), perfused with lactated Ringers (Baxter Deerfield, IL,USA) followed by 4% paraformaldehyde with 1% glutaraldehyde in 0.2 M cacodylate buffer for 15-minutes. Forhistology, brains were removed and post-fixed in 4% paraformaldehyde for 48-hours, and paraffin embedded. Forelectron microscopy, brains were removed and post-fixedfor 48-hours in perfusion buffer fixative.HistologyH & E slides were prepared from paraffin embeddedbrains. Sequential 10 μm thick coronal sections weremade within 0.5 mm of the Bregma line for sections including striatum and between Bregma 1.5 and 2.0 forsections including hippocampus [21].

Zinnanti et al. Acta Neuropathologica Communications 2014, ectron microscopyBrains were dissected into cortical, hippocampal or striatalblocks and embedded in Epon resin. Toluidine bluestained semithin Sections 1 μm thick were made fromthese blocks. Ultrathin sections of 90 nm were then cutfrom the same blocks and stained with uranyl acetate andlead citrate for transmission electron microscopic analysisusing a Philips CM10 transmission electron microscope.Page 3 of 15whole and then sectioned under dissecting microscope.Additional control animals were used with brief (2-3seconds) Evans blue injection followed by complete dissection to reliably differentiate arterial from venousstructures. Evans blue concentration was measured inbrain samples using spectrophotometry and correctedfor protein content as previously described [23].Western blot analysisImmunohistochemistry and confocal microscopyGlial fibrillary acidic protein (GFAP) and occludin (Occl)were detected using deparaffinized 10 μm thick coronalbrains sections. Sections were blocked with normalserum and doubled labeled with polyclonal anti-GFAP(1:500) (Dako, Carpenteria, CA, USA) and monoclonalanti-Occl (1:200) (Zymed, South San Francisco, CA,USA). Additional slides were prepared with GFAP labeling alone. All incubations were in PBS with normalserum overnight at 4 C. Double or single labeled slideswere washed separately 3 times each in PBS and incubated with goat anti-rabbit IgG coupled to Cy2 for GFAPand goat anti-mouse IgG coupled to Cy3 for Occl. Polyclonal GFAP alone was detected with goat anti-rabbitcoupled to horseradish peroxidase (all secondary antibodies diluted 1:2000; Jackson ImmunoResearch, WestGrove, PA, USA). All slides were counterstained with4’,6’-Diamidino-2-phenylindole (DAPI) 0.1 μg/ml in PBSfor 5 minutes. Confocal microscopy was performedusing a Leica TCS SP2 AOBS confocal microscope(Leica Microsystems Wetzlar, Germany).Capillary countsCapillaries were counted under 10 magnification of 1 μmthick semithin sections prepared as above. Coronal sections were examined from cortex, bregma zero; hippocampus, bregma-2.30 mm; and striatum, bregma zeroaccording to ‘The Mouse Brain in Stereotaxic Coordinates’ [21]. Total capillaries were counted within a300 μm 300 μm square section centered within the tissue sample. Capillaries were identified by the presence ofat least one endothelial cell lining the lumen with identifiable nucleus and the correct size of 3–5 μm [22].Occluded capillaries were counted as collapsed or withstasis, showing no patent lumen.Evans blue perfusionGcdh / , WT and Gcdh / mice were placed on thenormal or high protein diet for up to 72-hours (n 5 perdiet Gcdh / , n 3 per diet WT or Gcdh / ). Each animal was anesthetized as above and then perfusedthrough the heart with 5% solution of Evans blue in normal saline for 30-seconds. Animals were sacrificed andbrains were immersion fixed inside the skull for 48hours in 4% paraformaldehyde. Brains were examined inBrain protein extracts from mice from each treatmentgroup (20 μg each as determined by Bio-Rad proteinassay, Hercules, CA, USA) were loaded on 10% sodiumdodecyl sulfate-polyacrylamide gels and transferred ontonitrocellulose membranes, blocked in PBS-Tween 20(0.1%) containing 5% non-fat dry milk and 0.1% BSA for1 h at 4 C and incubated with monoclonal antibodiesagainst Occludin, ZO-1 (both from Zymed, South SanFrancisco, CA, USA), Hypoxia inducible factor 1 alpha(HIF-1α) (RD System, Abingdon, England), vascular endothelial growth factor (VEGF) (Santa Cruz Biotechnology,Santa Cruz, CA, USA) or anti phospho-occludin at Ser490 [24] overnight at 4 C. Blots were washed with PBSTween 20 (0.1%) and incubated with horseradish peroxidase conjugated anti-mouse IgG (1:10,000) for 2 h at 4 C.Immunoreactive bands were visualized using an enhancedchemiluminiscence system (ECL; Amersham Biosciences).Densitometric analysis of immunoreactive bands was performed by using ImageQuant 5.2 software (AmershamBiosciences) and results were expressed as percentage ofcontrol (WT standard diet). As a loading control wereprobed the blots with anti-actin (Sigma-Aldrich) inorder to control for small variability in the gel loading.MRI angiography and perfusionMagnetic resonance (MR) angiography and perfusion wasperformed on a 7.0 T Bruker system using a 2 mm birdcage coil. Gcdh / and WT mice were imaged at 0, 36, 72and 96-hours following the start of lysine diet (N 11Gcdh / , N 4 WT). Prior to imaging mice were anesthetized with 3% isoflurane, adjusted during the imaging to1–1.5% in order to maintain a constant breathing rate of40 bpm. Arterial spin labeling (ASL) was used to acquire asingle-slice perfusion-weighted image at the level of thestriatum (TR/TE 2000/12 ms, NAX 2, 1.06 mm slicethickness, 2082 μm2 in-plane resolution). A RARE sequence with multiple TR times (100-5000 ms), same sliceposition and resolution, was used to calculate T1 values.Perfusion values were calculated on a pixel by-pixel basisusing NIH Image J (NIH; rsbweb.nih.gov/ij/) and MRIanalysis calculator, a plug-in written by Karl Schmidt(NIH; rsbweb.nih.gov/ij/plugins/mri-analysis.html). MRangiography was done using a 3D gradient recalled echosequence (TR/TE 19/3 ms or TR/TE 100/3 ms inorder to allow slower moving blood to be visualized,

Zinnanti et al. Acta Neuropathologica Communications 2014, 73 μm3 voxel size, NAX 1), and maximum intensityprojection for image reconstruction.Page 4 of 15Four-week old Gcdh-/ -mice placed on an increased lysineor protein diet were shown previously to develop hemorrhages similar to human GA1 [16]. Therefore, we first examined gross brain specimens from control and Gcdh / mice placed on a standard or protein diet (60% protein) inorder to identify hemorrhage locations. Brief Evans blueinjection was used to differentiate arterial from venousstructures. Pathologic changes were limited to Gcdh / mice on the protein and lysine diet, in which venous dilation and engorgement developed within 36-48-hours.Enlarged veins were evident on the outer surface of thebrain (Figure 1a). Coronal sections showed substantial enlargement of internal cerebral veins that drain the caudate/putamen bilaterally (Figure 1b and e). On furtherdissection between the hippocampus and thalamus, symmetric dilation of the cerebral veins coalesced into a largedilated great vein of Galen (Figure 1e). These findings areconsistent with a recent report showing that brain injuryin children with GA1 was also associated with enlargement of the vein of Galen [4].Microscopic inspection of perfusion fixed brain fromGcdh / mice on the protein diet showed evidence ofhemorrhage (Figure 1f ) and BBB compromise as redblood cells were found outside the endothelial cell layer(Figure 1g). Additional immersion fixed brain sectionsshowed engorgement of larger non-exchange vessels(Figure 1h and i). Together these pathological changessuggest early filling of the venous system resulting in increased venous pressure, BBB breakdown and hemorrhage.Similar findings associated with venous dilation and engorgement have been reported in arteriovenous malformations where shunting of non-exchange vessels resultsin early filling of venous structures [25,26].after diet exposure to capture the evolution of this process.Cortical sections from Gcdh / mice on a standard dietshowed slightly increased perivascular spaces around somecapillaries compared to the normal morphology of Gcdh / controls (compare Figure 2a and b). Perivascular spacesbecome more pronounced at 24-hours after protein dietexposure in Gcdh / mice (Figure 2c). This change is associated with compromise of capillary lumens as some localaxons are edematous. Vacuoles fill axons of large corticalneurons (Figure 2d). These findings were previously demonstrated as the initial pathologic changes after protein orlysine diet exposure in Gcdh / mouse brain [17]. Thelocal expansion of these structures impinges on capillarieswith severe compromise of vessel lumens. This process isfurther elucidated by GFAP labeling in Gcdh / corticalsections at 36-hours after protein diet exposure (Figure 2e).GFAP labeling shows intact astrocyte end-feet surrounding capillary lumens with severe compromise via locallyexpanding vacuoles. These vacuoles are devoid of stainingindicating that they are not of astrocyte origin similar topreviously reported findings [17].We next used electron microscopy to inspect ultrastructural changes around brain capillaries at different timepoints after protein diet exposure (Figure 3). Multiple capillary lumina in Gcdh / mouse brain were compromisedwith increasing severity between 24 and 48-hours after protein diet exposure (Figure 3c-f). Gcdh / and Gcdh / cortex after 72 and 12-hours of protein exposure respectivelyshow normal vessel morphology (Figure 3a and b). In contrast, after 24-hours of protein diet, Gcdh / cortical capillaries showed compressed lumens impinged by edematousaxons and neuronal projections with swollen mitochondria(Figure 3c). Higher magnification of similar sections showedincreasing edema of dendrites in local neuropil with swellingof astrocyte end-feet after 36-hours (Figure 3d). At 36-hoursafter protein diet exposure some cortical capillaries showboth intact and swollen astrocyte end-feet with severelyswollen local neuronal projections and further compromiseof capillary lumina (Figure 3e). Swollen astrocyte end-feetare suggestive of post-ischemic changes within 5-hours ofischemic event [27]. After 48-hours of protein diet exposurewe observed capillaries that were severely compromisedwith surrounding expanded neuronal projections, identified by synapses with extensive mitochondrial swelling(Figure 3f). Together these findings confirm our previousobservation that neuronal swelling is the initial pathological change in Gcdh / mice exposed to a high proteindiet [17]. In addition we show that neuronal swelling appears to compromise local capillary lumina.Microscopic and ultrastructural changesIschemic changes in different brain regionsSince vessel changes were consistently found in 100% of the4-week old Gcdh / mice after initiation of protein diet, weexamined semi-thin sections from each of 12-hour intervalsCompromised capillaries were found with variable frequency at different time poi

A third type of stroke, known as metabolic stroke, begins with metabolic dys-function and leads to a rapid onset of lasting focal brain lesions in the absence of large vessel rupture or occlu-sion [3-5]. The mechanism by which global metabolic dysfunction leads to focal brain injury in metabolic stroke is not well understood. Pure metabolic .

Related Documents:

COUNTY Archery Season Firearms Season Muzzleloader Season Lands Open Sept. 13 Sept.20 Sept. 27 Oct. 4 Oct. 11 Oct. 18 Oct. 25 Nov. 1 Nov. 8 Nov. 15 Nov. 22 Jan. 3 Jan. 10 Jan. 17 Jan. 24 Nov. 15 (jJr. Hunt) Nov. 29 Dec. 6 Jan. 10 Dec. 20 Dec. 27 ALLEGANY Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open Open .

3 Double-Rocker Mechanism ①Car front wheel steering mechanism;②Aircraft landing gear mechanism;③Crane. 4 Slider-crank mechanism ①Engine; ②Umbrella; ③Closing mechanism of car door. 5 Guide rod mechanism ①Shaper; ②Dumper lorry. 6 Fixed-Slider Mechanism ①Hand

Keywords: Open access, open educational resources, open education, open and distance learning, open access publishing and licensing, digital scholarship 1. Introducing Open Access and our investigation The movement of Open Access is attempting to reach a global audience of students and staff on campus and in open and distance learning environments.

Network Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Blue Open Access POS Contract code 3UWH 3UWF 3UWD 3UWB 3UW9 3UW7 3UW5 Deductible1 (individual/family) 1,500/ 3,000 1,750/ 3,500 2,000/ 4,000 2,250/ 4,500 2,500/ 5,000 2,750/ 5,500 3,000/ 6,000

Double rocker mechanism Pantograph 68. APPLICATION link-1 fixed-CRANK-ROCKER MECHANISM OSCILLATORY MOTION 69. CRANK-ROCKER MECHANISM 70. Link 2 Fixed- DRAG LINK MECHANISM 71. Locomotive Wheel - DOUBLE CRANK MECHANISM 72. 2.SLIDER

conflict-of-interest factors. At a high level, access control policies are enforced through a mechanism that translates a user’s access request, often in terms of a structure that a system provides. An access control list is a familiar example of an access control mechanism. Access

Regional Acid Deposition Model, 2. nd. generation (RADM2) Regional Atmospheric Chemistry Mechanism ( RACM) RACM - Mainz Isoprene Mechanism (RACM-MIM) RACM - Earth System Research Laboratory ( RACM-ESRL), updated RACM-MIM Carbon Bond Mechanism (CB4) Carbon-Bond Mechanism version Z ( CBMZ)

What is Open Science? § Open Access to articles and lab notebooks § Open Data § Open Source Code § Open Collaboration (e.g., citizen science) § Open Technology (e.g., Makers) § Open Funding OECD (2015), "Making Open Science a Reality", OECD Science, Technology and Industry Policy Papers, No. 25, OECD Publishing,